1. Home
  2. ATYR vs AOUT Comparison

ATYR vs AOUT Comparison

Compare ATYR & AOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • AOUT
  • Stock Information
  • Founded
  • ATYR 2005
  • AOUT 2020
  • Country
  • ATYR United States
  • AOUT United States
  • Employees
  • ATYR N/A
  • AOUT N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • AOUT Ordnance And Accessories
  • Sector
  • ATYR Health Care
  • AOUT Industrials
  • Exchange
  • ATYR Nasdaq
  • AOUT Nasdaq
  • Market Cap
  • ATYR 126.3M
  • AOUT 110.0M
  • IPO Year
  • ATYR 2015
  • AOUT N/A
  • Fundamental
  • Price
  • ATYR $1.87
  • AOUT $8.98
  • Analyst Decision
  • ATYR Strong Buy
  • AOUT Strong Buy
  • Analyst Count
  • ATYR 4
  • AOUT 1
  • Target Price
  • ATYR $19.25
  • AOUT $11.00
  • AVG Volume (30 Days)
  • ATYR 435.2K
  • AOUT 23.0K
  • Earning Date
  • ATYR 11-07-2024
  • AOUT 11-29-2024
  • Dividend Yield
  • ATYR N/A
  • AOUT N/A
  • EPS Growth
  • ATYR N/A
  • AOUT N/A
  • EPS
  • ATYR N/A
  • AOUT N/A
  • Revenue
  • ATYR $588,000.00
  • AOUT $199,297,000.00
  • Revenue This Year
  • ATYR N/A
  • AOUT $2.64
  • Revenue Next Year
  • ATYR $2,057.88
  • AOUT $5.82
  • P/E Ratio
  • ATYR N/A
  • AOUT N/A
  • Revenue Growth
  • ATYR N/A
  • AOUT 4.36
  • 52 Week Low
  • ATYR $1.08
  • AOUT $7.19
  • 52 Week High
  • ATYR $2.50
  • AOUT $9.90
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 55.26
  • AOUT 51.39
  • Support Level
  • ATYR $1.67
  • AOUT $8.70
  • Resistance Level
  • ATYR $1.81
  • AOUT $9.23
  • Average True Range (ATR)
  • ATYR 0.08
  • AOUT 0.36
  • MACD
  • ATYR 0.00
  • AOUT 0.02
  • Stochastic Oscillator
  • ATYR 68.97
  • AOUT 61.86

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

Share on Social Networks: